Commission on Cancer Releases Updated Standards for 2020

The American College of Surgeons Commission on Cancer (CoC) was established in 1922 as “a consortium of professional organizations dedicated to improving survival and quality of life for cancer patients through standard-setting, prevention, research, education, and the monitoring of comprehensive quality care." Members include surgeons and more than 56 organizations including government agencies, patient advocacy groups, and more. The CoC establishes quality standards and accredits cancer programs based on those standards. Those standards and accredited programs are reviewed periodically to ensure the highest quality of care.

The CoC recently released its 2020 CoC accreditation standards, Optimal Resources for Cancer Care. The new standards are set for implementation beginning January 1, 2020 and continuing through 2021 for Phase-In standards.

Among the new additions are standards specific to breast, colorectal, skin, and lung cancer care.

Additionally, Standard 4.8 calls for the establishment of a Survivorship Program, combining elements from the old Survivorship Care Plan standard and recommendations from CoC and other member organizations. This new standard requires accredited organizations to establish a Survivorship Program under the guidance of the cancer committee. The appointed program coordinator and team will offer a slate of services such as treatment summaries, survivorship care plans, screening for recurrence and new cancers, rehabilitation services, support groups, psychological services, formalized referrals, or financial support services. This standard is intended to encompass all the survivorship care needs during and after treatment for the growing population of survivors.

To learn more, visit the CoC website to download the standards, check out in-person trainings and online webinar opportunities.

Latest News

Julie Bauman, MD, MPH, hosted a GW Medicine Bicentennial Series presentation featuring GW Cancer Center experts explaining how researchers have advanced cutting-edge treatments that empower the body’s natural immune system to fight cancer.
As an epidemiologist, Kim Robien is all about the data. Behind her science is the soul of someone whose direct work with cancer patients motivated her to find the answers to questions that weren’t always easily answered.
Figuring out how things work comes naturally to Greg Cresswell, who runs the GWCC Flow Cytometry Core Facility. When he’s not helping scientists across campus with studies ranging from cancer biology to frog immunology, he’s building and designing gadgets with his 3D printer. Getting to the nuts…